BIO-RAD laboratories:1110109 [15-000476]
Ended Awarded Last action
- Contract number
- HHSN26100017
- Awardee
-
Bio-Rad Laboratories, Inc. UEI SSHPDYFGN7J9 Part of Bio-Rad Laboratories, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,916
Award facts
- Contract value 100% obligated
- $3,916.00 Current and potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$356 | |
| Original award | $4,272 |
About this award
Bio-Rad Laboratories, Inc. was awarded a Blanket Purchase Agreement (BPA) call contract valued at $3,916.00 by the National Cancer Institute (NCI), a component of the National Institutes of Health, with a performance location in Bethesda, Maryland. This firm fixed-price contract, awarded on October 31, 2014, with an ultimate completion date of November 30, 2015, represents a call order against Bio-Rad's broader purchasing agreement vehicle. The award carries no small business set-aside designation, reflecting Bio-Rad's established position as a large, competitive federal contractor specializing in life science research and clinical diagnostics. Bio-Rad's Life Science Group Division supplies the NCI and other federal research agencies with advanced laboratory instrumentation, including polymerase chain reaction systems, thermal cyclers, imaging equipment, and specialized reagents supporting cancer research and diagnostic capabilities.
This contract award is consistent with Bio-Rad's extensive portfolio of federal procurement activities supporting the NIH and its institutes. The company maintains a significant $10 million BPA with the NIH Office of Logistics and Acquisition Operations through December 31, 2025, which facilitates the procurement of biological materials, chemicals, laboratory supplies, and specialized research instrumentation across multiple NIH institutes. The relatively modest ceiling value of this particular NCI call order suggests a targeted procurement of specific consumables or equipment components needed to support ongoing cancer research initiatives at the National Cancer Institute's Bethesda facility.
Quick answers
Who was awarded contract HHSN26100017?
HHSN26100017 was awarded to Bio-Rad Laboratories, Inc. by National Cancer Institute (National Institutes of Health) on October 31, 2014.
How much is contract HHSN26100017 worth?
The government has obligated $3,916 on HHSN26100017.
Is contract HHSN26100017 an order under another contract?
Yes. HHSN26100017 is a BPA call under HHSN263199800049653B, a blanket purchase agreement.
Was contract HHSN26100017 competed?
The extent of competition for HHSN26100017 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award